Perioperative Nivolumab in Resectable Lung Cancer.

Cascone T, Awad MM, Spicer JD, He J, Lu S, Sepesi B, Tanaka F, Taube JM, Cornelissen R, Havel L, Karaseva N, Kuzdzal J, Petruzelka LB, Wu L, Pujol JL, Ito H, Ciuleanu TE, de Oliveira Muniz Koch L, Janssens A, Alexandru A, Bohnet S, Moiseyenko FV, Gao Y, Watanabe Y, Coronado Erdmann C, Sathyanarayana P, Meadows-Shropshire S, Blum SI, Provencio Pulla M, CheckMate 77T Investigators

Open source

DOI: 10.1056/nejmoa2311926
Published: 2024 May 16
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2311926,
  title = {Perioperative Nivolumab in Resectable Lung Cancer.},
  author = {Cascone T and Awad MM and Spicer JD and He J and Lu S and Sepesi B and Tanaka F and Taube JM and Cornelissen R and Havel L and Karaseva N and Kuzdzal J and Petruzelka LB and Wu L and Pujol JL and Ito H and Ciuleanu TE and de Oliveira Muniz Koch L and Janssens A and Alexandru A and Bohnet S and Moiseyenko FV and Gao Y and Watanabe Y and Coronado Erdmann C and Sathyanarayana P and Meadows-Shropshire S and Blum SI and Provencio Pulla M and CheckMate 77T Investigators},
  year = {2024},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2311926},
  url = {https://doi.org/10.1056/nejmoa2311926}
}

RIS

TY  - JOUR
TI  - Perioperative Nivolumab in Resectable Lung Cancer.
AU  - Cascone T
AU  - Awad MM
AU  - Spicer JD
AU  - He J
AU  - Lu S
AU  - Sepesi B
AU  - Tanaka F
AU  - Taube JM
AU  - Cornelissen R
AU  - Havel L
AU  - Karaseva N
AU  - Kuzdzal J
AU  - Petruzelka LB
AU  - Wu L
AU  - Pujol JL
AU  - Ito H
AU  - Ciuleanu TE
AU  - de Oliveira Muniz Koch L
AU  - Janssens A
AU  - Alexandru A
AU  - Bohnet S
AU  - Moiseyenko FV
AU  - Gao Y
AU  - Watanabe Y
AU  - Coronado Erdmann C
AU  - Sathyanarayana P
AU  - Meadows-Shropshire S
AU  - Blum SI
AU  - Provencio Pulla M
AU  - CheckMate 77T Investigators
PY  - 2024
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2311926
UR  - https://doi.org/10.1056/nejmoa2311926
ER  -

APA

T, C., MM, A., JD, S., J, H., S, L., B, S., F, T., JM, T., R, C., L, H., N, K., J, K., LB, P., L, W., JL, P., H, I., TE, C., L, D. O. M. K., A, J., A, A., S, B., FV, M., Y, G., Y, W., C, C. E., P, S., S, M., SI, B., M, P. P., & Investigators, C. 7. (2024). Perioperative Nivolumab in Resectable Lung Cancer.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2311926

Source records

pubmed · retrieved 2026-09-25T21:16:18.315Z